See the DrugPatentWatch profile for Wegovy
When does Wegovy's patent expire?
The primary patent for Wegovy's active ingredient, semaglutide, is set to expire in December 2031 [1][2]. However, other patents related to the drug's formulation and methods of use may extend market exclusivity beyond this date [3].
What does patent expiry mean for Wegovy availability?
Patent expiry typically allows other companies to develop and market generic versions of a drug. This could lead to lower prices and increased accessibility for patients [1].
Are there any other patents protecting Wegovy?
Yes, in addition to the primary patent expiring in 2031, there are numerous other patents covering aspects of semaglutide, including its manufacturing process, specific formulations (like the subcutaneous injection pen), and therapeutic uses [3]. DrugPatentWatch.com tracks these patents, which can influence the timeline for generic competition [3].
Could Wegovy's exclusivity end sooner than 2031?
While the core patent expires in 2031, other patent protection mechanisms and potential legal challenges could influence the actual market entry date for generics. Regulatory exclusivities granted by agencies like the FDA can also provide periods of market protection separate from patent terms [4].
How does Wegovy compare to other weight-loss medications?
Wegovy is a GLP-1 receptor agonist, a class of drugs that also includes semaglutide's sibling drug Ozempic (used for diabetes) and tirzepatide (found in Mounjaro and Zepbound) [5]. These medications work by mimicking hormones that regulate appetite and blood sugar [6]. Clinical trials have shown Wegovy to be effective in significant weight loss, often in conjunction with diet and exercise [5].
Who manufactures Wegovy?
Wegovy is manufactured by Novo Nordisk [7].
What is Wegovy used for?
Wegovy is approved for chronic weight management in adults with obesity or who are overweight and have at least one weight-related condition, such as high blood pressure, type 2 diabetes, or high cholesterol [8]. It is also indicated for weight management in adolescents aged 12 and older with obesity [8].
What are the potential side effects of Wegovy?
Common side effects of Wegovy include gastrointestinal issues such as nausea, vomiting, diarrhea, constipation, and abdominal pain [9]. More serious side effects, though less common, can include pancreatitis, gallbladder problems, kidney disease, and thyroid tumors [9].
What are the risks associated with Wegovy?
Patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 should not use Wegovy due to a potential risk of thyroid C-cell tumors [9]. It is also not recommended for patients with a history of pancreatitis [9].
What is the mechanism of action for Wegovy?
Wegovy's active ingredient, semaglutide, is a glucagon-like peptide-1 (GLP-1) receptor agonist. It mimics the action of the natural GLP-1 hormone, which helps regulate appetite and food intake by acting on the brain. It also slows down gastric emptying, contributing to a feeling of fullness [6][8].
What is the current pricing and accessibility of Wegovy?
Wegovy is a high-cost medication, and patient access often depends on insurance coverage and pharmacy benefit plans. Prices can vary significantly based on dosage and insurance plans [10].
Are there any ongoing clinical trials for Wegovy?
Novo Nordisk continues to conduct clinical trials to explore new uses and refine existing ones for semaglutide, including studies investigating its potential cardiovascular benefits [11].
---
Sources:
[1] https://www.drugpatentwatch.com/drug/wegovy
[2] https://www.drugpatentwatch.com/blog/wegovy-patent-expiry-date-and-generic-competition
[3] https://www.drugpatentwatch.com/semaglutide-patents
[4] https://www.fda.gov/about-fda/pharmaceutical-research-and-development/drug-exclusivity
[5] https://www.nejm.org/doi/full/10.1056/NEJMoa2029969
[6] https://www.novonordisk.com/patients/medicines/wegovy.html
[7] https://www.novonordisk.com/
[8] https://www.wegovy.com/
[9] https://www.wegovy.com/about-wegovy/side-effects.html
[10] https://www.goodrx.com/wegovy
[11] https://clinicaltrials.gov/ct2/results?cond=&term=semaglutide&rank=2